Arne Gessner

625 total citations
24 papers, 429 citations indexed

About

Arne Gessner is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Arne Gessner has authored 24 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Arne Gessner's work include Drug Transport and Resistance Mechanisms (9 papers), Amino Acid Enzymes and Metabolism (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Arne Gessner is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Amino Acid Enzymes and Metabolism (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Arne Gessner collaborates with scholars based in Germany, Canada and China. Arne Gessner's co-authors include Martin F. Fromm, Jörg König, Andreas Bechthold, Renke Maas, David L. Zechel, Maulik Thaker, Lindsay Kalan, Nicholas Waglechner, Gerard D. Wright and Georg Schett and has published in prestigious journals such as Scientific Reports, European Heart Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Arne Gessner

20 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arne Gessner Germany 11 175 144 111 87 48 24 429
B. Kevin Park United Kingdom 10 95 0.5× 91 0.6× 111 1.0× 38 0.4× 160 3.3× 15 416
Fumio Itagaki Japan 13 128 0.7× 84 0.6× 123 1.1× 81 0.9× 72 1.5× 30 470
Kazutoshi Horie Japan 12 183 1.0× 299 2.1× 50 0.5× 164 1.9× 89 1.9× 17 508
Ling Huang China 13 184 1.1× 108 0.8× 33 0.3× 15 0.2× 86 1.8× 49 473
Arnaud Bruyère France 15 99 0.6× 267 1.9× 60 0.5× 146 1.7× 148 3.1× 35 595
Sui‐Lin Mo Australia 9 152 0.9× 101 0.7× 58 0.5× 31 0.4× 191 4.0× 12 406
Teiichiro Koga Japan 11 336 1.9× 92 0.6× 67 0.6× 26 0.3× 140 2.9× 14 645
Nathalie Maubon France 8 112 0.6× 245 1.7× 32 0.3× 85 1.0× 55 1.1× 10 478
Ágnes Telbisz Hungary 19 280 1.6× 473 3.3× 50 0.5× 108 1.2× 121 2.5× 29 827
Maxine Taylor United Kingdom 12 111 0.6× 83 0.6× 35 0.3× 48 0.6× 133 2.8× 14 436

Countries citing papers authored by Arne Gessner

Since Specialization
Citations

This map shows the geographic impact of Arne Gessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Gessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Gessner more than expected).

Fields of papers citing papers by Arne Gessner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Gessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Gessner. The network helps show where Arne Gessner may publish in the future.

Co-authorship network of co-authors of Arne Gessner

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Gessner. A scholar is included among the top collaborators of Arne Gessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Gessner. Arne Gessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gessner, Arne, Oliver Fischer, Peter Stopfer, et al.. (2025). In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions. Biochemical Pharmacology. 241. 117184–117184.
2.
3.
North, E. Jeffrey, Arne Gessner, Markus R. Heinrich, et al.. (2025). An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors. Clinical Chemistry and Laboratory Medicine (CCLM). 63(5). 1004–1015.
4.
Gessner, Arne, Jörg König, Markus R. Heinrich, et al.. (2024). New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. Clinical Pharmacology & Therapeutics. 117(1). 130–142. 5 indexed citations
5.
6.
Kachler, Katerina, Darja Andreev, Dmytro Royzman, et al.. (2024). Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Annals of the Rheumatic Diseases. 83(12). 1691–1706. 30 indexed citations
7.
Schulz, Sebastian, et al.. (2024). GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity. Cell Reports. 43(2). 113739–113739. 9 indexed citations
8.
9.
Gessner, Arne, Fabian Müller, Markus R. Heinrich, et al.. (2023). A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions. Clinical Pharmacology & Therapeutics. 114(5). 1058–1072. 13 indexed citations
10.
Müller, Fabian, Kathrin Hohl, Sascha Keller, et al.. (2023). N1‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid. Clinical Pharmacology & Therapeutics. 113(5). 1070–1079. 15 indexed citations
11.
Cao, Shan, Yixuan Li, Rui Song, et al.. (2023). L-arginine metabolism inhibits arthritis and inflammatory bone loss. Annals of the Rheumatic Diseases. 83(1). 72–87. 55 indexed citations
12.
Oswald, Stefan, Arne Gessner, R. Verena Taudte, et al.. (2022). Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors. Molecular Pharmacology. 102(6). 248–258. 9 indexed citations
13.
Gessner, Arne, Agnes Bosch, Dennis Kannenkeril, et al.. (2022). Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. Cardiovascular Diabetology. 21(1). 4–4. 9 indexed citations
14.
Gessner, Arne, Romina di Giuseppe, Manja Koch, et al.. (2020). Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort. Clinical Chemistry and Laboratory Medicine (CCLM). 58(5). 733–740. 32 indexed citations
15.
16.
Gessner, Arne, Maren Mieth, Daniel Auge, et al.. (2019). Establishment of reference values for the lysine acetylation marker Nɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method. Amino Acids. 51(9). 1259–1271. 6 indexed citations
17.
Gessner, Arne, Jörg König, & Martin F. Fromm. (2019). Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions. Clinical Pharmacology & Therapeutics. 105(6). 1386–1394. 97 indexed citations
18.
Gessner, Arne, Jörg König, & Martin F. Fromm. (2018). Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO). Scientific Reports. 8(1). 6659–6659. 24 indexed citations
19.
Kalan, Lindsay, Arne Gessner, Maulik Thaker, et al.. (2013). A Cryptic Polyene Biosynthetic Gene Cluster in Streptomyces calvus Is Expressed upon Complementation with a Functional bldA Gene. Chemistry & Biology. 20(10). 1214–1224. 56 indexed citations
20.
Al-Dilaimi, Arwa, Jochen Blom, Arne Gessner, et al.. (2012). Complete genome sequence of Saccharothrix espanaensis DSM 44229T and comparison to the other completely sequenced Pseudonocardiaceae. BMC Genomics. 13(1). 465–465. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kevin Park Breakdown of academic impact, for papers by Fumio Itagaki Breakdown of academic impact, for papers by Kazutoshi Horie Breakdown of academic impact, for papers by Ling Huang Breakdown of academic impact, for papers by Arnaud Bruyère Breakdown of academic impact, for papers by Sui‐Lin Mo Breakdown of academic impact, for papers by Teiichiro Koga Breakdown of academic impact, for papers by Nathalie Maubon Breakdown of academic impact, for papers by Ágnes Telbisz Breakdown of academic impact, for papers by Maxine Taylor
Rankless by CCL
2026